Publications by authors named "David Livermore"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

96

Total Likes

132

Extended Reach

373,158

Social Features

130
R
Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying 'breakpoints in brackets'.
Sara E Boyd, Mandy Wootton, Robin A Howe, David M Livermore, Alasdair P Macgowan

J Antimicrob Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of reviewing the package insert from gradient strip manufacturers.
Mandy Wootton, Leanne Davies, David M Livermore, Sara E Boyd, Alasdair MacGowan

J Antimicrob Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus position statement on advancing the classification of patients and tests of cure in studies of antibiotic treatment of complicated urinary tract infections.
Truls E Bjerklund Johansen, Christina Bahrs, Franck Bruyere, Tommaso Cai, Amelia Joseph, David M Livermore

Lancet Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: methods and limitations.
Michael Allen, Rosy Reynolds, Shazad Mushtaq, Olisaeloka Nsonwu, Russell Hope, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications and benefits of the British Society for Antimicrobial Chemotherapy Resistance Surveillance Project-legacy and future.
Benjamin J Parcell, Carolyne Horner, Rosy Reynolds, Michael Allen, Christopher Longshaw, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions.
Alasdair P MacGowan, Rosy Reynolds, Benjamin J Parcell, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends of serotypes and resistance among Streptococcus pneumoniae in the UK and Ireland (1999-2019).
Carolyne Horner, Rosy Reynolds, Shazad Mushtaq, Aiysha Chaudhry, Rachael Adkin, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance among agents of hospital-acquired lower respiratory tract infection in the UK and Ireland: trends from 2008/2009 to 2018/2019.
Rosy Reynolds, Ian Morrissey, Shazad Mushtaq, Carolyne Horner, Rachael Adkin, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance among Gram-positive agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019.
Rosy Reynolds, Shazad Mushtaq, Russell Hope, Carolyne Horner, Aiysha Chaudhry, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019.
Rosy Reynolds, David Felmingham, Shazad Mushtaq, Carolyne Horner, Aiysha Chaudhry, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial resistance among Gram-negative agents of bacteraemia in the UK and Ireland: trends from 2001 to 2019.
Rosy Reynolds, Shazad Mushtaq, Russell Hope, Carolyne Horner, Rachael Adkin, David M Livermore

J Antimicrob Chemother· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT.
Adam P Wagner, Virve I Enne, Vanya Gant, Susan Stirling, Julie A Barber, David M Livermore

Crit Care· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of rapid, ICU-based, syndromic PCR in hospital-acquired pneumonia: analysis of the INHALE WP3 multi-centre RCT.
Adam P Wagner, Virve I Enne, Vanya Gant, Susan Stirling, Julie A Barber, David M Livermore

Crit Care· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequencies and mechanisms of mutational resistance to ceftibuten/avibactam in Enterobacterales.
Shazad Mushtaq, Anna Vickers, Michel Doumith, Paolo Garello, Neil Woodford, David M Livermore

J Antimicrob Chemother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines vs mindlines: a qualitative investigation of how clinicians' beliefs influence the application of rapid molecular diagnostics in intensive care.
Sarah-Jane F Stewart, Alyssa M Pandolfo, Yogini Jani, Zoe Moon, David Brealey, David M Livermore

Antimicrob Agents Chemother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia.
Virve I Enne, Susan Stirling, Julie A Barber, Juliet High, Charlotte Russell, David M Livermore

Intensive Care Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional variations in antimicrobial susceptibility of community-acquired uropathogenic in India: Findings of a multicentric study highlighting the importance of local antibiograms.
Meher Rizvi, Shalini Malhotra, Jyotsna Agarwal, Areena H Siddiqui, Sheela Devi, David M Livermore

IJID Reg· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance.
Shazad Mushtaq, Anna Vickers, Neil Woodford, David M Livermore

Int J Antimicrob Agents· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist.
Angela Glen, Roland W Bürli, David Livermore, William Buffham, Stephanie Merison

Bioorg Med Chem Lett· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK clinicians' attitudes towards the application of molecular diagnostics to guide antibiotic use in ICU patients with pneumonias: a quantitative study.
Sarah-Jane F Stewart, Alyssa M Pandolfo, Zoe Moon, Yogini Jani, Stephen J Brett, David M Livermore

J Antimicrob Chemother· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: Impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in Escherichia coli.
David M Livermore, Shazad Mushtaq, Anna Vickers, Neil Woodford

Int J Antimicrob Agents· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of ertapenem/zidebactam (WCK 6777) against problem Enterobacterales.
Shazad Mushtaq, Paolo Garello, Anna Vickers, Neil Woodford, David M Livermore

J Antimicrob Chemother· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.
Sara E Boyd, Alison Holmes, Richard Peck, David M Livermore, William Hope

Antimicrob Agents Chemother· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
Hildegund C J Ertl, Sue L Currie, David M Livermore

Front Public Health· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis